Siedlecki; James M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Siedlecki; James M..The latest application filed is for "compounds and methods for treating autoimmune disorders by targeting hla-dq2".
- Siedlecki; James M. - Burlington MA
| Patent | Date |
|---|---|
| Compounds and Methods for Treating Autoimmune Disorders by Targeting HLA-DQ2 App 20220204471 - Perni; Robert B. ; et al. | 2022-06-30 |
| Compounds And Methods For Treating Autoimmune Disorders By Targeting Hla-dq2 App 20220055994 - Perni; Robert B. ; et al. | 2022-02-24 |
| Rifamycin analogs and uses thereof App 20100273765 - van Duzer; John H. ; et al. | 2010-10-28 |
| Rifamycin analogs and uses thereof Grant 7,547,692 - van Duzer , et al. June 16, 2 | 2009-06-16 |
| Rifamycin analogs and uses thereof Grant 7,494,991 - van Duzer , et al. February 24, 2 | 2009-02-24 |
| Rifamycin analogs and uses thereof Grant 7,488,726 - Van Duzer , et al. February 10, 2 | 2009-02-10 |
| Rifamycin analogs and uses thereof App 20070238747 - van Duzer; John H. ; et al. | 2007-10-11 |
| Rifamycin analogs and uses thereof Grant 7,271,165 - van Duzer , et al. September 18, 2 | 2007-09-18 |
| Rifamycin analogs and uses thereof App 20070155715 - van Duzer; John H. ; et al. | 2007-07-05 |
| Rifamycin analogs and uses thereof Grant 7,220,738 - van Duzer , et al. May 22, 2 | 2007-05-22 |
| Rifamycin analogs and uses thereof App 20070105849 - Van Duzer; John H. ; et al. | 2007-05-10 |
| Rifamycin analogs and uses thereof App 20050197333 - van Duzer, John H. ; et al. | 2005-09-08 |
| Rifamycin analogs and uses thereof App 20050137189 - van Duzer, John H. ; et al. | 2005-06-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 